206 related articles for article (PubMed ID: 2093018)
1. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
Brunner GH; Lamberts R; Creutzfeldt W
Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
[TBL] [Abstract][Full Text] [Related]
2. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Brunner G; Arnold R; Hennig U; Fuchs W
Aliment Pharmacol Ther; 1993; 7 Suppl 1():51-5, discussion 61-6. PubMed ID: 8490080
[TBL] [Abstract][Full Text] [Related]
3. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.
Brunner G; Creutzfeldt W; Harke U; Lamberts R
Digestion; 1988; 39(2):80-90. PubMed ID: 3410170
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine.
Brunner G; Creutzfeldt W
Scand J Gastroenterol Suppl; 1989; 166():101-5; discussion 111-3. PubMed ID: 2513641
[TBL] [Abstract][Full Text] [Related]
5. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Brunner G; Harke U
Aliment Pharmacol Ther; 1994; 8 Suppl 1():59-64. PubMed ID: 8180296
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P
Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
Hallerbäck B; Unge P; Carling L; Edwin B; Glise H; Havu N; Lyrenäs E; Lundberg K
Gastroenterology; 1994 Nov; 107(5):1305-11. PubMed ID: 7926494
[TBL] [Abstract][Full Text] [Related]
8. Long-term omeprazole treatment in man: effects on gastric endocrine cell populations.
Lamberts R; Creutzfeldt W; Stöckmann F; Jacubaschke U; Maas S; Brunner G
Digestion; 1988; 39(2):126-35. PubMed ID: 3410169
[TBL] [Abstract][Full Text] [Related]
9. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Lundell L; Backman L; Ekström P; Enander LK; Falkmer S; Fausa O; Grimelius L; Havu N; Lind T; Lönroth H
Scand J Gastroenterol; 1991 Mar; 26(3):248-56. PubMed ID: 1853146
[TBL] [Abstract][Full Text] [Related]
10. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Lundell L
Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
12. Clinical development programme for omeprazole.
Walan A
Digestion; 1990; 47 Suppl 1():54-8; discussion 76. PubMed ID: 2093016
[TBL] [Abstract][Full Text] [Related]
13. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.
Bianchi Porro G; Pace F; Peracchia A; Bonavina L; Vigneri S; Scialabba A; Franceschi M
J Clin Gastroenterol; 1992 Oct; 15(3):192-8. PubMed ID: 1479161
[TBL] [Abstract][Full Text] [Related]
14. Controlled clinical trials of omeprazole in the long-term management of reflux disease.
Hetzel DJ
Digestion; 1992; 51 Suppl 1():35-42. PubMed ID: 1397745
[TBL] [Abstract][Full Text] [Related]
15. Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole.
Creutzfeldt W; Lamberts R; Stöckmann F; Brunner G
Scand J Gastroenterol Suppl; 1989; 166():122-8; discussion 138-9. PubMed ID: 2513642
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S
Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777
[TBL] [Abstract][Full Text] [Related]
17. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB
Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161
[TBL] [Abstract][Full Text] [Related]
18. High doses of ranitidine in patients with reflux oesophagitis.
Jansen JB; Lamers CB
Scand J Gastroenterol Suppl; 1990; 178():42-6. PubMed ID: 2277968
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
20. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
Barradell LB; McTavish D
Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]